PetCure says 10,000 pets treated as radiation access expands

PetCure Oncology says it has now treated 10,000 pets with radiation therapy since launching in 2015, a milestone the company is framing as evidence that advanced veterinary radiation care has moved beyond a handful of academic centers and into a broader referral network. In its January 2026 announcement, PetCure said it now operates eight treatment centers nationwide, supported by 12 board-certified oncologists and eight supervising veterinarians, with roughly 1,000 patients treated per year. Company leaders, including Neal Mauldin, DVM, said the model was built to make stereotactic radiation therapy a more realistic option for community veterinarians and pet parents, especially by shortening many treatment courses to one to three sessions. (petage.com)

Why it matters: For veterinary professionals, the story isn't just about volume. It's about referral access, case logistics, and how radiation oncology is being integrated into everyday practice. The broader backdrop is still limited specialty capacity: the Veterinary Cancer Society maintains a national list of radiation facilities, underscoring that access remains uneven by geography. PetCure and Thrive have also continued investing in newer delivery platforms, including a Seattle launch tied to Empyrean Medical Systems' Sirius system, suggesting the company is still expanding the technology and footprint behind these referrals. (vetcancersociety.org)

What to watch: Watch whether PetCure's next phase is defined more by new sites and equipment deployments, or by whether it can materially widen access in regions that still have few veterinary radiation options. (empyreanmed.com)